Pomanda estimates the enterprise value of ADVANCED BIO-EXTRACTS LIMITED at £118.5k based on a Turnover of £183k and 0.65x industry multiple (adjusted for size and gross margin).
advanced bio-extracts limitedEstimated Valuation
£32.6k
Pomanda estimates the enterprise value of ADVANCED BIO-EXTRACTS LIMITED at £32.6k based on an EBITDA of £10.2k and a 3.2x industry multiple (adjusted for size and gross margin).
advanced bio-extracts limitedEstimated Valuation
£152.4k
Pomanda estimates the enterprise value of ADVANCED BIO-EXTRACTS LIMITED at £152.4k based on Net Assets of £79.5k and 1.92x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Advanced Bio-extracts LimitedOverview
Advanced Bio-extracts Limited is a live company located in newcastle, ST5 5AN with a Companies House number of 03934485. It operates in the research and experimental development on biotechnology sector, SIC Code 72110. Founded in February 2000, it's largest shareholder is
patrick henfrey
with a 62% stake. Advanced Bio-extracts Limited is a mature,
micro sized company, Pomanda has estimated its turnover at
£183k with
low
growth in recent years.
Pomanda's financial health check has awarded Advanced Bio-Extracts Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 6 areas for improvement. Company Health Check FAQs
Health Rating3.5out of 5
3 Strong
1 Regular
6 Weak
Size
annual sales of £183k, make it smaller than the average company (£3.7m)
£183k - Advanced Bio-extracts Limited
£3.7m - Industry AVG
Growth
3 year (CAGR) sales growth of 3%, show it is growing at a slower rate (10.2%)
3% - Advanced Bio-extracts Limited
10.2% - Industry AVG
Production
with a gross margin of 24.8%, this company has a higher cost of product (49.4%)
24.8% - Advanced Bio-extracts Limited
49.4% - Industry AVG
Profitability
an operating margin of 5.6% make it more profitable than the average company (0.8%)
5.6% - Advanced Bio-extracts Limited
0.8% - Industry AVG
Employees
with 1 employees, this is below the industry average (38)
1 - Advanced Bio-extracts Limited
38 - Industry AVG
Pay Structure
on an average salary of £68.5k, the company has an equivalent pay structure (£68.5k)
£68.5k - Advanced Bio-extracts Limited
£68.5k - Industry AVG
Efficiency
resulting in sales per employee of £183k, this is more efficient (£128.4k)
£183k - Advanced Bio-extracts Limited
£128.4k - Industry AVG
Debtor Days
it gets paid by customers after 154 days, this is later than average (56 days)
154 days - Advanced Bio-extracts Limited
56 days - Industry AVG
Creditor Days
its suppliers are paid after 0 days, this is quicker than average (45 days)
0 days - Advanced Bio-extracts Limited
45 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Advanced Bio-extracts Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Advanced Bio-extracts Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 0.2%, this is a lower level of debt than the average (53.2%)
0.2% - Advanced Bio-extracts Limited
53.2% - Industry AVG
ADVANCED BIO-EXTRACTS LIMITED financials
EXPORT
Advanced Bio-Extracts Limited's latest turnover from December 2023 is estimated at £183 thousand and the company has net assets of £79.5 thousand. According to their latest financial statements, we estimate that Advanced Bio-Extracts Limited has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Dec 2012
Dec 2011
Dec 2010
Dec 2009
Turnover
183,012
159,263
160,624
167,480
179,963
181,699
164,180
174,571
Other Income Or Grants
Cost Of Sales
137,609
118,377
121,047
122,621
131,968
133,528
119,788
127,371
Gross Profit
45,403
40,886
39,577
44,859
47,995
48,171
44,391
47,200
Admin Expenses
35,227
37,963
39,577
47,227
45,072
50,539
41,468
49,568
Operating Profit
10,176
2,923
-2,368
2,923
-2,368
2,923
-2,368
Interest Payable
Interest Receivable
Pre-Tax Profit
10,176
2,923
-2,368
2,923
-2,368
2,923
-2,368
-16
Tax
-2,544
-555
-555
-555
Profit After Tax
7,632
2,368
-2,368
2,368
-2,368
2,368
-2,368
-16
Dividends Paid
Retained Profit
7,632
2,368
-2,368
2,368
-2,368
2,368
-2,368
-16
Employee Costs
68,495
64,593
63,438
59,022
58,074
56,978
52,674
50,787
Number Of Employees
1
1
1
1
1
1
1
1
1
1
EBITDA*
10,176
2,923
-2,368
2,923
-2,368
2,923
-2,368
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Dec 2012
Dec 2011
Dec 2010
Dec 2009
Tangible Assets
2,366
2,368
2,366
2,366
2,366
Intangible Assets
2,366
2,366
Investments & Other
2,366
2,366
Debtors (Due After 1 year)
Total Fixed Assets
2,366
2,368
2,366
2,366
2,366
2,366
2,366
2,366
2,366
Stock & work in progress
Trade Debtors
77,299
69,617
69,617
69,617
69,617
69,617
69,617
69,617
69,617
Group Debtors
Misc Debtors
69,617
Cash
misc current assets
total current assets
77,299
69,617
69,617
69,617
69,617
69,617
69,617
69,617
69,617
69,617
total assets
79,665
71,985
71,983
71,983
71,983
71,983
71,983
71,983
71,983
69,617
Bank overdraft
Bank loan
Trade Creditors
180
132
130
130
130
130
130
130
130
130
Group/Directors Accounts
other short term finances
hp & lease commitments
other current liabilities
total current liabilities
180
132
130
130
130
130
130
130
130
130
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
total long term liabilities
total liabilities
180
132
130
130
130
130
130
130
130
130
net assets
79,485
71,853
71,853
71,853
71,853
71,853
71,853
71,853
71,853
69,487
total shareholders funds
79,485
71,853
71,853
71,853
71,853
71,853
71,853
71,853
71,853
69,487
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Dec 2012
Dec 2011
Dec 2010
Dec 2009
Operating Activities
Operating Profit
10,176
2,923
-2,368
2,923
-2,368
2,923
-2,368
Depreciation
Amortisation
Tax
-2,544
-555
-555
-555
Stock
Debtors
7,682
69,617
Creditors
48
2
130
Accruals and Deferred Income
Deferred Taxes & Provisions
Cash flow from operations
-2
2,370
-2,368
2,368
-2,368
2,368
-2,368
-69,487
Investing Activities
capital expenditure
2
-2
-2,366
2,366
-2,366
2,366
-2,366
Change in Investments
-2,366
2,366
-2,366
2,366
cash flow from investments
2
-2
-2,366
Financing Activities
Bank loans
Group/Directors Accounts
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue
-2,368
2,368
-2,368
2,368
-2,368
2,368
2,366
69,503
interest
cash flow from financing
-2,368
2,368
-2,368
2,368
-2,368
2,368
2,366
69,503
cash and cash equivalents
cash
overdraft
change in cash
advanced bio-extracts limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for advanced bio-extracts limited. Get real-time insights into advanced bio-extracts limited's credit score, group structure and payment trends.
Perform a competitor analysis for advanced bio-extracts limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other micro companies, companies in ST5 area or any other competitors across 12 key performance metrics.
advanced bio-extracts limited Ownership
ADVANCED BIO-EXTRACTS LIMITED group structure
Advanced Bio-Extracts Limited has no subsidiary companies.
Ultimate parent company
ADVANCED BIO-EXTRACTS LIMITED
03934485
ADVANCED BIO-EXTRACTS LIMITED Shareholders
The largest shareholders in Advanced Bio-Extracts Limited include Patrick Henfrey and Gunter Feddern.
patrick henfrey
62%
gunter feddern
10%
erwin protzen
10%
jeremy lefroy
6%
robert arathoon
6%
barnabas gaston
6%
advanced bio-extracts limited directors
Advanced Bio-Extracts Limited currently has 4 directors.
The longest serving directors include
Mr Patrick Henfrey (Feb 2000) and
Mr Erwin Protzen (Aug 2002).
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to advanced bio-extracts limited.
advanced bio-extracts limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for ADVANCED BIO-EXTRACTS LIMITED. This can take several minutes, an email will notify you when this has completed.
advanced bio-extracts limitedCompanies House Filings - See Documents
